Holding(s) in Company

RNS Number : 8314C
Spire Healthcare Group PLC
23 June 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BNLPYF73

Issuer Name

SPIRE HEALTHCARE GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

The Goldman Sachs Group, Inc.

City of registered office (if applicable)

Wilmington, Delaware

Country of registered office (if applicable)

USA

4. Details of the shareholder

Name

City of registered office

Country of registered office

Goldman Sachs International

London

United Kingdom

5. Date on which the threshold was crossed or reached

18-Jun-2021

6. Date on which Issuer notified

22-Jun-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.778566

1.301233

5.079799

20374240

Position of previous notification (if applicable)

4.219760

1.228105

5.447865


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BNLPYF73


15155208


3.778566

Sub Total 8.A

15155208

3.778566%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Swap

13/09/2021


4925475

1.228042

Sub Total 8.B1


4925475

1.228042%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

CFD

20-Jul-2022


Cash

205029

0.051119

CFD

18-Jun-2024


Cash

88315

0.022019

Swap

09-Sep-2021


Cash

213

0.000053

Sub Total 8.B2


293557

0.073191%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Goldman Sachs Group, Inc. (Chain 1)




0.000000


Goldman Sachs (UK) L.L.C.

3.740721

1.301180

5.041901


Goldman Sachs Group UK Limited

3.740721

1.301180

5.041901


Goldman Sachs International

3.740721

1.301180

5.041901

The Goldman Sachs Group, Inc. (Chain 2)




0.000000


Goldman Sachs & Co. LLC



0.000000

The Goldman Sachs Group, Inc. (Chain 3)




0.000000


GSAM Holdings LLC



0.000000


Goldman Sachs Asset Management, L.P.



0.000000

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Please note, the total amount of voting rights have been rounded to 6 decimal places therefore there is a possibility of a rounding error.

General email contact:
gs-regops-emea-position-enquiries@gs.com  

12. Date of Completion

22-Jun-2021

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUOVWRAUUNURR
UK 100

Latest directors dealings